iSpecimen Inc.

ISPC ·Healthcare, Diagnostics & Research, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Operating Activities
Net Income $-2.1M $-2.9M $-3.1M $-2.1M $-3.5M $-2.4M $-2.2M $-3.1M
Depreciation & Amortization $606.7K $596.7K — — — — — —
Depreciation $16.1K $16.1K $18.4K $23.4K $37.1K $38.6K $8.8K $4.5K
Amortization $47.9K $47.9K $43.1K $6.4K $0 $0 $357.0K $292.7K
Stock-Based Compensation $79.6K $93.9K $108.1K $106.3K $124.7K $120.6K $45.1K $219.9K
Net Cash from Operating Activities $-1.5M $-2.1M $345.1K $-1.6M $-1.7M $-2.8M $-207.4K $-2.3M
Investing Activities
Capital Expenditures $0 $9.1K $0 $5.7K $5.7K $8.0K — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $295.1K $1.9M $-723.0K $2.4M $-68.0K $-8.8M $-1.6M $-772.1K
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $0 $52.5K — — — — — —
Net Cash from Financing Activities $1.3M $-118.9K $0 $0 $3.2K $67.7K $-3.5M $-5.0K
Net Change in Cash — — — — — — — —
Free Cash Flow $-1.5M $-2.1M $345.1K $-1.6M $-1.7M $-2.8M — —
← Newer Page 2 of 3 Older →